1-3 of 3
Saliba M Rima, MD
Close
Sort by
Journal Articles

Improved Progression-Free Survival with Minimal Toxicity after Allogeneic Hematopoietic Stem Cell Transplantation in Older Patients with Hematological Malignancy

Betul Oran, MD, Saliba M. Rima, MD, Borje S Andersson, MD PhD, Marcos J de Lima, MD, Uday R. Popat, MD, Issa F. Khouri, MD, Partow Kebriaei, Qaiser Bashir, Sairah Ahmed, MD, Elizabeth J Shpall, MD, Richard E. Champlin, Gabriela Rondon, MD
Journal: Blood
Blood (2014) 124 (21): 2533.
https://doi.org/10.1182/blood.V124.21.2533.2533
Published: 2014
Journal Articles

Bortezomib and BEAM-Rituximab Reduced-Intensity Conditioning for High-Risk Lymphoma Patients Who Are Not Eligible for Nonmyeloablative Allogeneic Stem Cell Transplantation

Issa F. Khouri, MD, Saliba M. Rima, MD, Francesco Turturro, MD, Martin Korbling, MD, Celina Ledesma, Gabriela Rondon, MD, Amin M. Alousi, M.D., Paolo Anderlini, MD, Qaiser Bashir, MD, Stefan O. Ciurea, Chitra M. Hosing, M.D., Uday R. Popat, M.D., Yasmeen Charafeddine, Yasuhiro Oki, MD, Luis E Fayad, MD, Richard E. Champlin
Journal: Blood
Blood (2012) 120 (21): 4157.
https://doi.org/10.1182/blood.V120.21.4157.4157
Published: 2012
Journal Articles

Ex-Vivo T Cell-Depleted Versus Unmodified Allografts in Patients with Acute Myeloid Leukemia in First Complete Remission: A Comparison of Outcomes in Two Institutions

Ulas D. Bayraktar, MD, Marcos De Lima, MD, Saliba M Rima, MD, Molly Maloy, Hugo Castro-Malaspina, MD, Julianne J Chen, Gabriela Rondon, MD, Alexandre Chiattone, MD, Ann A. Jakubowski, MD, PhD, Farid Boulad, MD, Nancy A. Kernan, MD, Richard J. O'Reilly, MD, Richard Champlin, MD, Sergio A Giralt, MD, Borje S Andersson, MD, PhD, Esperanza B Papadopoulos, MD
Journal: Blood
Blood (2011) 118 (21): 2013.
https://doi.org/10.1182/blood.V118.21.2013.2013
Published: 2011